Results 161 to 170 of about 42,535 (241)

Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage, Becky Bishop, Vikki Mangano, Baher Mankabady   +3 more
wiley   +1 more source

Telehealth abortion services via Women on Web in Kenya (2013-2019): a descriptive analysis of the characteristics and motivations of the care seekers. [PDF]

Sex Reprod Health Matters
Ouma MA, Alaze A, Juma K, Atay H, Gomperts R, Miani C.   +5 more
europepmc   +1 more source

Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Xylazine, an alpha‐2‐adrenergic agonist, has been increasingly implicated in substance use and overdose crises. However, little is known about its effects on humans. With the growing public health crisis surrounding xylazine, it has become important to recognize and promptly manage symptoms of xylazine toxicity ...
Philipa Owusu‐Antwi, Priya Atodaria, Edmund Appiah‐Kubi, Zainab Shah, Elpidio Marlon Garcia   +4 more
wiley   +1 more source

Efficacy of a four-drug combined regimen compared to uterine curettage in the treatment of incomplete medical abortion: a prospective observational study. [PDF]

J Health Popul Nutr
Feng Y, Zhang L.
europepmc   +1 more source

Using synthetic farm data to estimate individual nitrate leaching levels

American Journal of Agricultural Economics, EarlyView.
Abstract This article delineates a synthetic population generation scheme in an attempt to estimate individual nitrate leaching rates among Greek farms in the region of Thessaly. The proposed scheme relies upon the construction of a Bayesian network describing farming activities in the region, which, coupled with the use of nonparametric regression ...
Konstantinos Mattas, Michail Tsagris, Vangelis Tzouvelekas   +2 more
wiley   +1 more source

The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone. [PDF]

BioTech (Basel)
Louttit C.
europepmc   +1 more source

Induced Abortion After Previous Caesarean Section: A Scoping Review

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Previous caesarean section (CS) is increasingly common among women undergoing induced abortion. Aims To map and analyse existing literature on abortion safety, outcomes and management in those with previous CS. Materials and Methods Four databases were systematically searched from inception to July 2024.
Natalie Drever, Vinay Gangathimmaiah, Brittany van Der Lugt, Cecelia O'Brien, Catriona Melville, Kirsten Black, Caroline de Costa   +6 more
wiley   +1 more source

Obstetricians' views on extending the 12-week abortion limit in Belgium: A qualitative study. [PDF]

PLoS One
De Meyer F, Beernaert K, Van de Velde S, Sterckx S, Van Assche K.   +4 more
europepmc   +1 more source

Knowledge and Awareness of Cardiovascular Risk Factors Among Women With a History of Pregnancy Complications in Australia: A World Heart Federation Cross‐Sectional Study

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Cardiovascular disease (CVD) is the leading cause of death worldwide, and women who experience complications during pregnancy, such as pregnancy loss (miscarriage and stillbirth), hypertensive disorders of pregnancy and gestational diabetes, have a significantly higher risk of future CVD. Increasing awareness of CVD risk among these
Farnoosh Asghar Vahedi, Leila Gholizadeh, Marjan Khajehei   +2 more
wiley   +1 more source

Ferroptosis and recurrent miscarriage: a critical review of pathophysiology and emerging therapeutic targets. [PDF]

Front Cell Dev Biol
Khodaei MM, Noori Z, Zare F, Meshkin A.
europepmc   +1 more source